Physician profile
Sara L Simons
NPI 1528447984
$1,849.55
in general payments reported to CMS, 2019-2025
28 companies · $500 in 2025
The $500 reported for 2025 was more than what 80% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $208 · 2020: $175 · 2021: $194 · 2022: $86.71 · 2023: $379 · 2024: $308 · 2025: $500.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,186.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $211.63 | 2024-2025 | Zurzuvae |
| Exeltis, USA INC. | $176.13 | 2019-2025 | Slynd |
| Mayne Pharma Commercial LLC | $130.79 | 2023-2025 | |
| Organon LLC | $127.76 | 2021-2025 | Nexplanon |
| Abbvie INC. | $120.32 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $111.79 | 2019 | |
| Astellas Pharma US INC | $104.47 | 2023-2025 | Veozah |
| Hologic Sales and Service, LLC | $96.77 | 2022-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Acessa Provu System |
| Pfizer INC. | $95.16 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $86.08 | 2020-2023 | Gardasil 9 |
| Daiichi Sankyo INC. | $68.12 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $63.64 | 2024-2025 | Myfembree |
| Intuitive Surgical, INC. | $62.71 | 2022-2024 | |
| Kedrion Biopharma, INC. | $54.61 | 2023-2024 | Rhogam Ultra-Filtered Plus, Albuked, Gammaked |
| Coopersurgical, INC. | $40.91 | 2023-2025 | Paragard T 380a |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $38.81 | 2025 | Femlyv |
| Aspira Women'S Health INC | $31.42 | 2020 | |
| Smith+Nephew, INC. | $30.07 | 2021 | |
| Lupin INC. | $29.21 | 2020 | |
| Baxter Healthcare | $28.20 | 2025 | Perclot |
| Gynesonics, INC. | $22.49 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Amag Pharmaceuticals, INC. | $22.07 | 2020 | |
| Medicem INC. | $21.20 | 2023 | |
| Evofem Biosciences, INC. | $18.37 | 2021 | |
| Exact Sciences Corporation | $16.49 | 2023 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $14.20 | 2020 | |
| Therapeuticsmd, INC. | $13.18 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $12.95 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Simons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.